WO2023042081 - )-4-SUBSTITUTED CYCLOHEXANE-1-AMINES
National phase entry:
Publication Number
WO/2023/042081
Publication Date
23.03.2023
International Application No.
PCT/IB2022/058641
International Filing Date
14.09.2022
Title **
[English]
)-4-SUBSTITUTED CYCLOHEXANE-1-AMINES
[French]
)-4
Applicants **
RICHTER GEDEON NYRT.
BUDAPESTI MŰSZAKI ÉS GAZDASÁGTUDOMÁNYI EGYETEM
Inventors
FARKAS, Emese
POPPE, László
HORNYÁNSZKY, Gábor
INCZE, Dániel János
ÉLES, János
SÁNTA-BELL, Evelin
MOLNÁR, Zsófia Klára
SZEMES, József
SCHNEIDER, Anna
CSUKA, Pál
Priority Data
P2100325
15.09.2021
HU
P2200363
13.09.2022
HU
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 3709 | |
| EPO | Filing, Examination, Granting | 34298 | |
| Japan | Filing, Examination, Granting | 3419 | |
| South Korea | Filing, Examination, Granting | 4553 | |
| USA | Filing, Examination, Granting | 18340 |
Total:
64,319
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
-4-((1,3-dioxolan-2-yl)methyl)cyclohexan-1-amine may be produced.[French]
-4-((1,3-dioxolan-2-yl)méthyl)cyclohexane-1-amine.